Archive media & news
Galenica remains on growth track
Ad hoc announcement, 2025/10/23
Galenica demonstrates pleasing growth and improves EBIT guidance
Ad hoc announcement, 2025/08/07
Galenica to enter the diagnostics business by acquiring Labor Team
Ad hoc announcement, 2025/07/02
Galenica continues sales growth
Ad hoc announcement, 2025/05/22
Galenica continues to grow in 2024
Ad hoc announcement, 2025/03/11
Galenica reports strong sales growth once again
Ad hoc announcement, 2025/01/23
Galenica increases sales growth in the third quarter
Ad hoc announcement, 2024/10/24
Galenica achieves solid growth in a challenging market environment
Ad hoc announcement, 2024/08/06
Galenica on track with sales growth
Ad hoc announcement, 2024/05/23
Galenica continues to grow in the 2023 financial year
Ad hoc announcement, 2024/03/12
Galenica again achieves strong sales growth
Ad hoc announcement, 2024/01/18
Galenica Investor Day: Updated mid-term guidance and strategy update
Ad hoc announcement, 2023/10/24
Galenica achieves strong sales growth in the first half of 2023
Ad hoc announcement, 2023/08/08
Galenica lowers EBIT guidance 2023 due to special factors – Sales and dividend outlook confirmed
Ad hoc announcement, 2023/07/25
Green light for Switzerland’s leading online pharmacy
Ad hoc announcement, 2023/05/11
Galenica achieves strong results in 2022 and increases dividend again
Ad hoc announcement, 2023/03/07
Change to the Board of Directors of the Galenica Group
Ad hoc announcement, 2023/01/19
2022 Galenica Group sales
Ad hoc announcement, 2023/01/19
Galenica Group half-year results 2022
Ad hoc announcement, 2022/08/09